Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice-Reference-Cited by-同舟云学术

Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice

Published:2020-04-14 Issue:15 Volume:11 Page:1388-1398
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Watabe Tadashi¹²,Kaneda-Nakashima Kazuko²³,Shirakami Yoshifumi²,Liu Yuwei¹,Ooe Kazuhiro¹²,Teramoto Takahiro²,Toyoshima Atsushi²,Shimosegawa Eku²⁴,Nakano Takashi²⁵,Kanai Yoshikatsu⁶,Shinohara Atsushi²⁷,Hatazawa Jun²⁵

Affiliation:

1. Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita, Japan

2. Institute for Radiation Sciences, Osaka University, Suita, Japan

3. Core for Medicine and Science Collaborative Research and Education, Project Research Center for Fundamental Sciences, Graduate School of Science, Osaka University, Toyonaka, Japan

4. Department of Molecular Imaging in Medicine, Graduate School of Medicine, Osaka University, Suita, Japan

5. Research Center for Nuclear Physics, Osaka University, Ibaraki, Japan

6. Department of Bio-system Pharmacology, Graduate School of Medicine, Osaka University, Suita, Japan

7. Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice;eBioMedicine;2024-07

2. Targeted Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and Clinical Trials;Targeted Oncology;2024-06-05

3. Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics;EJNMMI Radiopharmacy and Chemistry;2024-02-26

4. Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice;Bioengineering;2023-12-26

5. Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors;Clinical Nuclear Medicine;2023-08-30